CDC Online Newsroom - CDC Advisory - CDC Statement on Oseltamivir (Tamiflu) Resistance and Antiviral Recommendations

This page is a historical archive and is no longer maintained.

For current information, please visit http://www.cdc.gov/media/

Media Advisory

For Immediate Release: August 30, 2007
Contact: Division of News & Electronic Media, Office of Communication
(404) 639-3286

CDC Statement on Oseltamivir (Tamiflu) Resistance and Antiviral Recommendations

WHO:

Dr. Melinda Wharton, Deputy Director National Center for Immunizations and Respiratory Diseases (NCIRD)

WHAT:

MMWR Telebriefing
CDC will announce 2006 national and state vaccination coverage rates among young children and adolescents.
(This is the first time adolescents have been included in the National Immunization Survey.)

WHEN:

Thursday, August 30, 2007, 11:30 a.m. ET
Brief remarks followed by Q&A.

DIAL-IN:

1-888-795-0855, Passcode: CDC Media

MMWR Telebriefing:

Scheduled for 11:30 A.M. August 30, 2007
This briefing will also be audio web cast. To listen LIVE online: http://www.videonewswire.com/event.asp?id=42118.

Important Instructions:

If you would like to ask a question during the call, press *1 on your touchtone phone. Press *2 to withdraw your question. You may queue up at any time. You will hear a tone to indicate your question is pending.

TRANSCRIPT

A transcript of this media availability will be available following the briefing at the CDC web site at www.cdc.gov/media.

###
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO